NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bioventus Inc (NASDAQ: BVS)

 
BVS Technical Analysis
2
As on 1st Aug 2025 BVS STOCK Price closed @ 6.18 and we RECOMMEND Sell for LONG-TERM with Stoploss of 8.17 & Strong Buy for SHORT-TERM with Stoploss of 4.86 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BVSSTOCK Price

Open 6.45 Change Price %
High 6.50 1 Day -0.34 -5.21
Low 6.03 1 Week -0.29 -4.48
Close 6.18 1 Month -0.25 -3.89
Volume 526076 1 Year 1.78 40.45
52 Week High 13.71 | 52 Week Low 3.96
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 173.72 -2.33%
OPEN 2.10 14.13%
EQ 0.71 82.05%
AMZN 214.75 -8.27%
NCNA 0.04 0.00%
LMDX 0.02 0.00%
BTAI 1.37 4.58%
AKTS 0.04 0.00%
AAPL 202.38 -2.50%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
HCTI 4.75 15733.33%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
ORGS 1.00 1566.67%
REDU 3.41 1075.86%
DRMA 6.45 940.32%
CTXRW 0.14 600.00%
NBSTU 12.99 220.74%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
OTRKP 0.02 -60.00%
HEPA 0.05 -58.33%
 
 
BVS
Daily Charts
BVS
Intraday Charts
Whats New @
Bazaartrend
BVS
Free Analysis
 
BVS Important Levels Intraday
RESISTANCE7.09
RESISTANCE6.80
RESISTANCE6.62
RESISTANCE6.44
SUPPORT5.92
SUPPORT5.74
SUPPORT5.56
SUPPORT5.27
 
BVS Forecast August 2025
4th UP Forecast9.65
3rd UP Forecast8.54
2nd UP Forecast7.85
1st UP Forecast7.16
1st DOWN Forecast5.2
2nd DOWN Forecast4.51
3rd DOWN Forecast3.82
4th DOWN Forecast2.71
 
BVS Weekly Forecast
4th UP Forecast7.90
3rd UP Forecast7.35
2nd UP Forecast7.01
1st UP Forecast6.67
1st DOWN Forecast5.69
2nd DOWN Forecast5.35
3rd DOWN Forecast5.01
4th DOWN Forecast4.46
 
BVS Forecast2025
4th UP Forecast26.37
3rd UP Forecast19.9
2nd UP Forecast15.89
1st UP Forecast11.89
1st DOWN Forecast0.47
2nd DOWN Forecast-3.53
3rd DOWN Forecast-7.54
4th DOWN Forecast-14.01
 
 
BVS Other Details
Segment EQ
Market Capital 853309504.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
BVS Address
BVS
 
BVS Latest News
 
Your Comments and Response on Bioventus Inc
 
BVS Business Profile
Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company provides osteoarthritic joint pain treatment and joint preservation products, including Durolane, a single injection therapy; GELSYN-3, a three injection therapy; and SUPARTZ FX, a five injection therapy. It also offers bone graft substitutes comprising allograft-derived bone graft with growth factors, demineralized bone matrix, cancellous bone in different preparations, bioactive synthetics, collagen ceramic matrix, and bone marrow isolation systems. In addition, the company provides Exogen systems for the non-invasive treatment of established nonunion fractures and certain fresh fractures. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina. Address: 4721 Emperor Boulevard, Durham, NC, United States, 27703
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service